Common use of SUPPLEMENTAL INDENTURE NO Clause in Contracts

SUPPLEMENTAL INDENTURE NO. 1 SUPPLEMENTAL INDENTURE No. 1 dated as of [_______], 2022 (this “Supplemental Indenture”) among Healthcare Trust of America Holdings, LP, a Delaware limited partnership (hereinafter called the “Issuer”), Healthcare Trust of America, Inc., a Maryland corporation (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx, Xxxxx 000, Xxxxxxxxxx, Xxxxxxx 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______], 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] aggregate principal amount of 3.875% Senior Notes due 2025 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.

SUPPLEMENTAL INDENTURE NO. 1 2 SUPPLEMENTAL INDENTURE No. 1 2 dated as of [_______]July 22, 2022 (this “Supplemental Indenture”) among Healthcare Realty Holdings, L.P., a Delaware limited partnership (f/k/a Healthcare Trust of America Holdings, LP, a Delaware limited partnership partnership) (hereinafter called the “Issuer”), Healthcare Realty Trust Incorporated, a Maryland corporation (f/k/a Healthcare Trust of America, Inc., a Maryland corporation corporation) (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx0000 Xxxx Xxx Xxxxxx, Xxxxx 000, XxxxxxxxxxXxxxxxxxx, Xxxxxxx XX 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______]July 22, 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] 290,245,000 aggregate principal amount of 3.8753.625% Senior Notes due 2025 2028 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.

SUPPLEMENTAL INDENTURE NO. 1 4 SUPPLEMENTAL INDENTURE No. 1 4 dated as of [_______], 2022 (this “Supplemental Indenture”) among Healthcare Trust of America Holdings, LP, a Delaware limited partnership (hereinafter called the “Issuer”), Healthcare Trust of America, Inc., a Maryland corporation (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx, Xxxxx 000, Xxxxxxxxxx, Xxxxxxx 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______], 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] aggregate principal amount of 3.8752.050% Senior Notes due 2025 Due 2031 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.

SUPPLEMENTAL INDENTURE NO. 1 3 SUPPLEMENTAL INDENTURE No. 1 3 dated as of [_______]July 22, 2022 (this “Supplemental Indenture”) among Healthcare Realty Holdings, L.P., a Delaware limited partnership (f/k/a Healthcare Trust of America Holdings, LP, a Delaware limited partnership partnership) (hereinafter called the “Issuer”), Healthcare Realty Trust Incorporated, a Maryland corporation (f/k/a Healthcare Trust of America, Inc., a Maryland corporation corporation) (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx0000 Xxxx Xxx Xxxxxx, Xxxxx 000, XxxxxxxxxxXxxxxxxxx, Xxxxxxx XX 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______]July 22, 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] 297,503,000 aggregate principal amount of 3.8752.400% Senior Notes due 2025 2030 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.

SUPPLEMENTAL INDENTURE NO. 1 2 SUPPLEMENTAL INDENTURE No. 1 2 dated as of [_______], 2022 (this “Supplemental Indenture”) among Healthcare Trust of America Holdings, LP, a Delaware limited partnership (hereinafter called the “Issuer”), Healthcare Trust of America, Inc., a Maryland corporation (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx, Xxxxx 000, Xxxxxxxxxx, Xxxxxxx 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______], 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] aggregate principal amount of 3.8753.625% Senior Notes due 2025 2028 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.

SUPPLEMENTAL INDENTURE NO. 1 4 SUPPLEMENTAL INDENTURE No. 1 4 dated as of [_______]July 22, 2022 (this “Supplemental Indenture”) among Healthcare Realty Holdings, L.P., a Delaware limited partnership (f/k/a Healthcare Trust of America Holdings, LP, a Delaware limited partnership partnership) (hereinafter called the “Issuer”), Healthcare Realty Trust Incorporated, a Maryland corporation (f/k/a Healthcare Trust of America, Inc., a Maryland corporation corporation) (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx0000 Xxxx Xxx Xxxxxx, Xxxxx 000, XxxxxxxxxxXxxxxxxxx, Xxxxxxx XX 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______]July 22, 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] 298,858,000 aggregate principal amount of 3.8752.050% Senior Notes due 2025 Due 2031 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.

SUPPLEMENTAL INDENTURE NO. 1 3 SUPPLEMENTAL INDENTURE No. 1 3 dated as of [_______], 2022 (this “Supplemental Indenture”) among Healthcare Trust of America Holdings, LP, a Delaware limited partnership (hereinafter called the “Issuer”), Healthcare Trust of America, Inc., a Maryland corporation (hereinafter called the “Guarantor” or, in its capacity as the sole general partner of the Issuer, the “General Partner”), each having its principal office at 00000 X. Xxxxxxxxxx Xxxx, Xxxxx 000, Xxxxxxxxxx, Xxxxxxx 00000, and U.S. Bank Trust Company, National Association, as trustee hereunder (hereinafter called the “Trustee”). The Issuer and the Trustee are parties to an Indenture, dated as of [_______], 2022 (the “Base Indenture”), which provides for the issuance by the Issuer from time to time of debt securities in one or more series. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is herein referred to as the “Indenture.” Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Base Indenture. The Issuer has authorized the issuance of $[ ] aggregate principal amount of 3.8752.400% Senior Notes due 2025 2030 (the “Notes”) guaranteed by the Guarantor. The Issuer desires to enter into this Supplemental Indenture pursuant to Section 9.01(i) of the Base Indenture, without the consent of Holders, to establish the form and terms of the Notes as new series of Debt Securities as permitted by Sections 2.01 and Section 2.02 of the Base Indenture.